Dolutegravir (DTG)

Strength: 50 mg

Dosage Form: Tablet

Description:

Dolutegravir is an integrase strand transfer inhibitor (INSTI) that blocks the HIV integrase enzyme, preventing viral DNA from integrating into the host genome and stopping HIV replication.

Key Features:

• Once-daily dosing without food restrictions
• High barrier to resistance development
• Rapid viral load reduction
• Generally well tolerated

Precautions:

• Possible hypersensitivity reactions; seek immediate medical help if rash or fever occurs
• May interact with certain other medications
• Monitor liver enzymes if co-infected with hepatitis